340B Drug Pricing Program
The Supreme Court of the United States Nov. 30 will hear oral arguments in a case brought by the AHA and others asking the court to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to certain…
The AHA last Friday called the government’s defense of the decision by the Department of Health and Human Services to cut reimbursement to certain hospitals participating in the 340B program by nearly 30% “meritless” as it again urged the U.S. Supreme Court to overturn a lower court decision…
The government does not dispute that the agency singled out Section 340B hospitals as a group and set their reimbursement based on acquisition cost rather than price, without conducting the cost study that the statute requires. The agency’s action was therefore contrary to law.
On the November 17, 2021, AHA 340B Advocacy Alliance Call, AHA staff provided updates on the latest activity on the 340B Drug Pricing Program including regulatory, legislative and legal actions related to the program.
The AHA 340B Advocacy Alliance Wednesday, Nov. 17, at 3 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program.
The AHA 340B Advocacy Alliance Nov. 17 at 3 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program.
The AHA 340B Advocacy Alliance Nov. 17 at 3 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program.
November 5, 2021
UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
ORDERED that the plaintiffs' Motions for Summary Judgment, Dkt. 19 (Novartis), Dkt. 14 (United Therapeutics) are GRANTED IN PART and DENIED IN PART.
This case concerns conditions that plaintiffs Novartis Pharmaceuticals Corporation and
United Therapeutics Corporation have imposed on discounted drug purchases by certain safetynet
health care providers.